Prevalence of Restless Legs Syndrome Among Psychiatric Patients Who are Under Antidepressant or Antipsychotic Monotherapy

Semiz M., Solmaz V., AKSOY D., Inanir S., ÇOLAK B., Gokbakan M. A., ...Daha Fazla

KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, cilt.26, sa.2, ss.161-168, 2016 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 26 Sayı: 2
  • Basım Tarihi: 2016
  • Doi Numarası: 10.5455/bcp.20150908024954
  • Dergi Adı: KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.161-168
  • Anahtar Kelimeler: antidepressant, antipsychotic, restless legs syndrome, adverse effect, PERIODIC LIMB MOVEMENTS, RATING-SCALE, QUETIAPINE, DEPRESSION, MIRTAZAPINE, SCHIZOPHRENIA, SLEEP, ASSOCIATION, ROPINIROLE, OLANZAPINE
  • Ankara Üniversitesi Adresli: Hayır

Özet

Objective: Several groups of medications, such as dopamine blockers, analgesics and antihistaminergics were associated with restless legs syndrome (RLS). Although case reports showed some significant relations, they have many methodological limitations such as co-medications or medical co-morbidities. The aim of this study was to investigate the prevalence and severity of RLS in patients on antidepressant (AD) or antipsychotic (AP) monotherapy.